MARSHALL WACE, LLP - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,409,593
-69.6%
147,144
-74.8%
0.01%
-68.3%
Q2 2023$21,111,590
+2.8%
584,323
+5.7%
0.04%
-6.8%
Q1 2023$20,546,189
+68.0%
552,614
+562.9%
0.04%
+91.3%
Q4 2021$12,229,000
+71.8%
83,364
+107.2%
0.02%
-23.3%
Q3 2021$7,117,000
-1.4%
40,232
-10.0%
0.03%
-9.1%
Q2 2021$7,221,000
-11.3%
44,702
-6.0%
0.03%
-10.8%
Q1 2021$8,144,000
-90.0%
47,544
-87.2%
0.04%
-91.6%
Q4 2020$81,401,000
+14.4%
370,606
-13.5%
0.44%
-3.1%
Q3 2020$71,136,000
+7279.3%
428,399
+5625.7%
0.46%
+6400.0%
Q4 2019$964,000
+35.4%
7,482
-22.9%
0.01%
+133.3%
Q1 2019$712,000
+8800.0%
9,706
+4753.0%
0.00%
Q4 2018$8,000
-97.0%
200
-97.7%
0.00%
-100.0%
Q1 2018$268,0008,7400.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,000,000$31,470,0008.67%
Baker Brothers Advisors 2,805,074$88,276,0000.77%
Broadfin Capital, LLC 359,661$11,319,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 397,660$12,514,0000.42%
Boulegeris Investments, Inc. 17,415$548,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 95,000$2,990,0000.29%
Rhenman & Partners Asset Management AB 50,000$1,574,0000.19%
Integre Asset Management, LLC 23,996$755,0000.16%
Orbimed Advisors 680,500$21,415,0000.16%
EAM Investors, LLC 38,754$1,220,0000.14%
View complete list of MIRATI THERAPEUTICS INC shareholders